OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

ABUS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Arbutus Biopharma (ABUS) Earnings Date & Reports

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ABUS is expected to report earnings to fall 66.15% to -4 cents per share on July 31

Arbutus Biopharma ABUS Stock Earnings Reports

Q2'25

Est.

$-0.04

Q1'25

Missed

by $0.03

Q4'24

Beat

by $0.02

Q3'24

Missed

by $0.01

Q2'24

Missed

by $0.01

The last earnings report on May 14 showed earnings per share of -12 cents, missing the estimate of -10 cents. With 1.84M shares outstanding, the current market capitalization sits at 599.48M.

View a ticker or compare two or three

Compare

ABUS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ABUS
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

View to see Real Time Patterns for ABUS (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of drugs to improve the treatment of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

701 Veterans Circle

Phone

+1 267 469-0914

Employees

Web

http://www.arbutusbio.com